BioSpace News Archive

Collaboration Includes Exclusive Rights and Targets for Initial Applications in Non-Hodgkin Lymphoma, Leukemia and Multiple Myeloma

DaVita clinical leaders push for innovation through new research

R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, announced results for the three months ended September 30, 2019.

Simultaneous delivery of two optimized AAV vectors expands the therapeutic and commercial potential of AGTC’s industry-leading AAV platform by enabling delivery of DNA encoding larger proteins

Dr. Howard Mayer, Executive Vice-President and Head of Research and Development, effective December 1st, 2019

LHC Group, Inc. and LifePoint Health have announced an agreement to further expand their existing joint venture partnership with the purchase of one home health provider with a location in Wilmington, Ohio, and two hospice providers located in Sierra Vista, Ariz., and Lewiston, Idaho.

Aerie Pharmaceuticals, Inc. reported positive topline results for the Company’s Phase 2 clinical trial evaluating netarsudil ophthalmic solution in Japanese patients.

Regeneron Pharmaceuticals, Inc. provided an update on the ongoing Phase 3 development program evaluating Libtayo®, a PD-1 inhibitor, as monotherapy and combination therapy in first-line patients with advanced non-small cell lung cancer Regeneron is currently recruiting patients in two Phase 3 trials in first-line NSCLC.

Novel procedure marks a pivotal step in implementation of robotics to address neurovascular disease

Codexis, Inc., a leading protein engineering company, announces that management will participate in four upcoming investment conferences